NCT05184387View on ClinicalTrials.gov

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

July 12, 2022

Study Completion Date

July 12, 2022

Conditions
Influenza
Interventions
OTHER

Blood samples

Collection of blood samples and completion of an electronic Diary (eDiary)

Trial Locations (1)

9000

Centre for Vaccinology (CEVAC), Ghent

Sponsors

Lead Sponsor

Osivax
All Listed Sponsors
collaborator

Center for vaccinology (CEVAC), University of Ghent, Belgium

UNKNOWN

lead

Osivax

INDUSTRY

NCT05184387 - A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness. | Biotech Hunter | Biotech Hunter